SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Jun-24 4:12 PM View: | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | 100% 0 to 2.5K | |
17-Jan-24 5:21 PM View: | Mersana Therapeutics, Inc. (MRSN) | 16-Jan-24 | Planned Option Sale | 29,399 | $2.71 | $79,671.30 | (6%) 467.06K to 437.66K | |
17-Jan-24 5:21 PM View: | Mersana Therapeutics, Inc. (MRSN) | 15-Jan-24 | Option Exercise | 38,958 | -- | -- | 9% 428.1K to 467.06K | |
17-Jan-24 5:21 PM View: | Mersana Therapeutics, Inc. (MRSN) | 14-Jan-24 | Option Exercise | 16,750 | -- | -- | 4% 411.35K to 428.1K | |
17-Jan-24 5:21 PM View: | Mersana Therapeutics, Inc. (MRSN) | 13-Jan-24 | Option Exercise | 31,250 | -- | -- | 8% 380.1K to 411.35K | |
20-Dec-23 4:58 PM View: | Nuvalent, Inc. (NUVL) | 18-Dec-23 | Option Exercise | 5,000 | $9.36 | $46,800.00 | 100% 0 to 5.0K | |
20-Dec-23 4:58 PM View: | Nuvalent, Inc. (NUVL) | 18-Dec-23 | Option Sale | 5,000 | $75.67 | $378,350.00 | (100%) 5.0K to 0 | |
13-Sep-23 4:02 PM View: | Mersana Therapeutics, Inc. (MRSN) | 11-Sep-23 | Grant | 16,643 | -- | -- | 5% 363.46K to 380.1K | |
18-Jan-23 8:24 PM View: | Mersana Therapeutics, Inc. (MRSN) | 17-Jan-23 | Option Sale | 17,346 | $5.74 | $99,566.00 | (5%) 378.59K to 361.24K | |
18-Jan-23 8:24 PM View: | Mersana Therapeutics, Inc. (MRSN) | 15-Jan-23 | Option Exercise | 38,958 | -- | -- | 11% 339.63K to 378.59K | |
18-Jan-23 8:24 PM View: | Mersana Therapeutics, Inc. (MRSN) | 14-Jan-23 | Option Exercise | 16,750 | -- | -- | 5% 322.88K to 339.63K | |
18-Jan-23 8:24 PM View: | Mersana Therapeutics, Inc. (MRSN) | 20-May-22 | Gift | 240,244 | -- | -- | 74% 322.88K to 563.12K | |
18-Jan-23 8:24 PM View: | Mersana Therapeutics, Inc. (MRSN) | 20-May-22 | Gift | 240,244 | -- | -- | (43%) 563.12K to 322.88K | |
19-Jan-22 6:01 PM View: | Mersana Therapeutics, Inc. (MRSN) | 14-Jan-22 | Option Exercise | 38,958 | -- | -- | 14% 283.92K to 322.88K | |
19-Jul-21 8:49 PM View: | Mersana Therapeutics, Inc. (MRSN) | 19-Jul-21 | Market Option Sale | 21,901 | $12.02 | $263,250.00 | (7%) 304.88K to 282.98K | |
19-Jul-21 8:49 PM View: | Mersana Therapeutics, Inc. (MRSN) | 16-Jul-21 | Market Option Sale | 20,043 | $12.47 | $249,936.00 | (6%) 324.92K to 304.88K | |
19-Jul-21 8:49 PM View: | Mersana Therapeutics, Inc. (MRSN) | 15-Jul-21 | Option Exercise | 100,000 | -- | -- | 44% 224.92K to 324.92K | |
07-Jun-21 9:34 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 03-Jun-21 | Option Exercise | 3,333 | -- | -- | 100% 0 to 3.33K | |
20-Jan-21 7:04 PM View: | Mersana Therapeutics, Inc. (MRSN) | 15-Jan-21 | Payment of Exercise | 5,198 | $21.09 | $109,626.00 | (2%) 230.12K to 224.92K | |
20-Jan-21 7:04 PM View: | Mersana Therapeutics, Inc. (MRSN) | 15-Jan-21 | Option Exercise | 17,709 | -- | -- | 8% 212.41K to 230.12K | |
08-Mar-18 12:53 PM View: | Bioverativ Inc. (BIVV) | 08-Mar-18 | Disposition | 1,056 | -- | -- | (100%) 1.06K to 0 | |
21-Dec-17 4:06 PM View: | Mersana Therapeutics, Inc. (MRSN) | 20-Dec-17 | Option Exercise | 10,417 | $1.53 | $15,938.00 | 5% 192.56K to 202.98K | |
06-Jul-17 5:18 PM View: | Mersana Therapeutics, Inc. (MRSN) | 03-Jul-17 | Conversion | 72,263 | -- | -- | 60% 120.3K to 192.56K | |
17-Apr-17 4:14 PM View: | Bioverativ Inc. (BIVV) | 17-Apr-17 | Grant | 1,056 | $56.83 | $60,012.50 | 100% 0 to 1.06K | 85% |
16-Feb-17 2:15 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 16-Feb-17 | Disposition | 41,910 | -- | -- | (100%) 41.91K to 0 | |
01-Feb-17 4:54 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 31-Jan-17 | Grant | 18,008 | -- | -- | 75% 23.9K to 41.91K | |
03-Feb-16 4:56 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 01-Feb-16 | Grant | 23,902 | -- | -- | 100% 0 to 23.9K | |
15-May-08 3:32 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 14-May-08 | Disposition | 123,350 | $25.00 | $3,083,750.00 | (100%) 123.35K to 0 | < 1% |
12-May-08 5:11 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 09-May-08 | Disposition (change in control) | 46,723 | $25.00 | $1,168,080.00 | (27%) 170.07K to 123.35K | < 1% |
05-May-08 4:11 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 01-May-08 | Market Sale (Planned) | 2,041 | $24.88 | $50,780.10 | (1%) 177.96K to 175.92K | < 1% |
11-Mar-08 4:43 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 07-Mar-08 | Market Sale (Planned) | 2,010 | $13.34 | $26,812.80 | (1%) 177.93K to 175.92K | (87%) |
04-Mar-08 9:37 AM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 29-Feb-08 | Market Sale (Planned) | 4,289 | $13.67 | $58,647.90 | (2%) 182.22K to 177.93K | (82%) |
19-Feb-08 4:52 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 19-Feb-08 | Option Exercise | 3,561 | $8.12 | $28,933.10 | 2% 182.22K to 185.78K | |
19-Feb-08 4:52 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 19-Feb-08 | Market Option Sale (Planned) | 3,561 | $14.03 | $49,960.80 | (2%) 185.78K to 182.22K | (78%) |
19-Feb-08 4:52 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 14-Feb-08 | Grant | 54,145 | -- | -- | 42% 128.07K to 182.22K | |
22-Jan-08 4:06 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 18-Jan-08 | Option Exercise | 3,812 | $8.12 | $30,972.50 | 3% 128.07K to 131.89K | |
22-Jan-08 4:06 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 18-Jan-08 | Market Option Sale (Planned) | 3,812 | $16.53 | $63,012.40 | (3%) 131.89K to 128.07K | (51%) |
09-Jan-08 4:38 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 08-Jan-08 | Market Sale (Planned) | 1,071 | $15.23 | $16,311.30 | (< 1%) 129.15K to 128.07K | (64%) |
07-Jan-08 4:29 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 03-Jan-08 | Market Sale (Planned) | 4,091 | $16.11 | $65,906.00 | (3%) 133.24K to 129.15K | (55%) |
19-Dec-07 4:02 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 17-Dec-07 | Option Exercise | 71,875 | $8.41 | $604,469.00 | 54% 132.37K to 204.24K | |
19-Dec-07 4:02 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 17-Dec-07 | Option Exercise | 71,875 | $14.61 | $1,050,090.00 | (35%) 204.24K to 132.37K | (71%) |
03-Dec-07 4:09 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 03-Dec-07 | Market Sale (Planned) | 5,674 | $14.55 | $82,556.70 | (4%) 138.04K to 132.37K | (72%) |
27-Nov-07 4:39 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 26-Nov-07 | Market Sale (Planned) | 5,000 | $14.32 | $71,600.00 | (3%) 143.04K to 138.04K | (74%) |
20-Nov-07 4:35 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 19-Nov-07 | Market Sale (Planned) | 5,000 | $13.62 | $68,100.00 | (3%) 148.04K to 143.04K | (83%) |
13-Nov-07 4:27 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 12-Nov-07 | Market Sale (Planned) | 5,000 | $13.41 | $67,050.00 | (3%) 153.04K to 148.04K | (86%) |
06-Nov-07 10:56 AM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 05-Nov-07 | Market Sale (Planned) | 5,000 | $12.62 | $63,100.00 | (3%) 158.04K to 153.04K | (98%) |
02-Nov-07 4:03 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 01-Nov-07 | Market Sale (Planned) | 368 | $12.00 | $4,416.00 | (< 1%) 158.41K to 158.04K | (108%) |
18-Sep-07 4:29 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 17-Sep-07 | Option Exercise | 25,674 | $4.91 | $125,964.00 | 19% 132.37K to 158.04K | |
01-May-07 4:10 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 01-May-07 | Market Sale (Planned) | 1,929 | $11.07 | $21,354.00 | (1%) 134.3K to 132.37K | (125%) |
10-Apr-07 4:12 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 09-Apr-07 | Option Exercise | 4,250 | $6.88 | $29,240.00 | 3% 132.37K to 136.62K |